Accordingly, gemcitabine and Bmi1 siRNA enhanced active caspase-3, active caspase-9 and cleaved poly (ADP-ribose) polymerase-1 in pancreatic cancer cells, and these enhancements could be also suppressed by NAC treatment (Figure 3F). Here, PARP1 is linked to pancreatic neoplasm.